Combined chemotherapy and external beam radiotherapy for transitional cell carcinoma of the bladder

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current Oncology Reports

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11912-004-0054-XPMID 15066235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.

  2003cited by this paper
• Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.

  2003cited by this paper
• RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.

  2003cited by this paper
• Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

  2003cited by this paper
• Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

  2003cited by this paper
• Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil.

  2002cited by this paper
• Neoadjuvant Chemotherapy with Cisplatin and Methotrexate in Patients with Muscle-Invasive Bladder Tumours

  2002cited by this paper
• Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.

  2002cited by this paper
• Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer.

  2002cited by this paper
• An Organ-sparing Treatment Using Combined Intra-arterial Chemotherapy and Radiotherapy for Muscle-invading Bladder Carcinoma

  2002cited by this paper
• Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

  2001cited by this paper
• Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.

  2001cited by this paper
• Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.

  2001cited by this paper
• Phase 1/2 Study of Synchronous Methotrexate, Cisplatin, Vincristine (MOPq10) Chemotherapy and Radiation for Patients with Locally Advanced Bladder Cancer

  2001cited by this paper
• A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer.

  2001cited by this paper
• Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors.

  2001cited by this paper
• Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: A well‐tolerated combination

  2000cited by this paper
• Intra-operative electron radiotherapy as a conservative treatment for infiltrating bladder cancer.

  2000cited by this paper
• Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial.

  2000cited by this paper
• The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response.

  2000cited by this paper
• Predicting the survival of bladder carcinoma patients treated with radical cystectomy

  2000cited by this paper
• A bladder preservation regimen using intra‐arterial chemotherapy and radiotherapy for invasive bladder cancer: A prospective study

  2000cited by this paper
• Bladder preservation by internal iliac arterial infusion chemotherapy and irradiation in T3 bladder carcinoma patients over the age of 70 years.

  2000cited by this paper
• Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.

  2000cited by this paper
• Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma

  1999cited by this paper
• Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.

  1999cited by this paper
• Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort.

  1999cited by this paper
• Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.

  1999cited by this paper
• The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience.

  1998cited by this paper
• Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of radiation therapy oncology group 89-03.

  1998cited by this paper
• Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer.

  1998cited by this paper
• A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.

  1998cited by this paper
• Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee.

  1997cited by this paper
• Combined intraarterial chemotherapy and radiotherapy in the treatment of Bladder carcinoma

  1997cited by this paper
• Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.

  1997cited by this paper
• Bladder preservation by combined modality therapy for invasive bladder cancer.

  1997cited by this paper
• Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.

  1996cited by this paper
• Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

  1996cited by this paper
• Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time.

  1995cited by this paper
• Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors.

  1994cited by this paper
• Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial.

  1994cited by this paper
• Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.

  1993cited by this paper
• Bladder cancer definitive radiation therapy of muscle‐invasive bladder cancer: A retrospective analysis of 317 patients

  1993cited by this paper
• Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12.

  1993cited by this paper
• Definitive radiotherapy in bladder cancer

  1993cited by this paper
• Intraarterial cisplatin and concurrent pelvic radiation in the management of muscle invasive bladder cancer

  1992cited by this paper
• FIGO stage IIIA carcinoma of the uterine cervix.

  1992cited by this paper
• Dose fractionation and tumour repopulation in radiotherapy for bladder cancer.

  1991cited by this paper
• Effective surgical adjuvant therapy for high-risk rectal carcinoma.

  1991cited by this paper
• Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder.

  1991cited by this paper
• Effective surgical adjuvant therapy for high-risk rectal carcinoma.

  1991cited by this paper
• Prognostic factors in patients with bladder carcinoma treated with definitive irradiation

  1990cited by this paper
• Radiotherapy with and without cisplatin in bladder cancer.

  1990cited by this paper
• Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis.

  1989cited by this paper
• Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer.

  1989cited by this paper
• Preliminary results of treatment of invasive bladder carcinoma with radiotherapy and cisplatin.

  1988cited by this paper
• Invasive bladder carcinoma. The importance of initial transurethral surgery and other significant prognostic factors for improved survival with full‐dose irradiation

  1987cited by this paper
• Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery.

  1987cited by this paper
• The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy.

  1986cited by this paper
• Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control.

  1986cited by this paper
• Irradiation therapy with multiple small fractions per day in urinary bladder cancer.

  1985cited by this paper
• Bladder carcinoma: Experiences with radical and preoperative radiotherapy in 421 patients

  1984cited by this paper
• Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group

  1981cited by this paper
• Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy.

  1981cited by this paper
• Bladder cancer: results of radiation therapy in 384 patients.

  1975cited by this paper
• Advanced cancer of the urinary bladder. An analysis of the results of radiotherapy alone vs. radiotherapy and concomitant 5-fluorouracil; a prospective randomized study of 36 cases.

  1970cited by this paper

• The Particular Role of Radiopharmacy within Bioorganometallic Chemistry

  2007cites this paper